Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Soma
Generic Name: Carisoprodol
Carisoprodol is a skeletal muscle relaxant intended for short term use in the treatment of pain caused by muscle spasms.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Fibromyalgia | 168 | 41 |
|
|
|
|
|
| Muscle spasms | 118 | 32 |
|
|
|
|
|
| Muscle pain | 81 | 23 |
|
|
|
|
|
| Stiffness/Spasticity | 48 | 10 |
|
|
|
|
|
| Pain | 29 | 4 |
|
|
|
||
| Other | 23 | 8 |
|
|
|
See all 474 patients currently taking Carisoprodol
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Carisoprodol
| Sleepiness | 21 | |
|---|---|---|
| Grogginess | 12 | |
| Drowsiness | 10 | |
| Excessive daytime sleepiness (somnolence) | 5 | |
| Dry mouth (xerostomia) | 5 | |
| Nausea | 4 | |
| See all 37 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Carisoprodol. See all 40 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 29 | ||
| Doctor's advice | 27 | ||
| Other | 23 | ||
| Side effects too severe | 14 | ||
| Course of treatment ended | 10 | ||
| Change in health plan coverage | 5 | ||
| Personal research | 4 | ||
| Expense | 1 | ||
| Not indicated | 1 |
Adherence
Taking treatment as prescribed
Adherence of Carisoprodol
Always |
72 | 61% |
|
|---|---|---|---|
Usually |
29 | 24% |
|
Sometimes |
15 | 13% |
|
Never |
3 | 3% |
|
Burden
Difficulty being on treatment
Burden of Carisoprodol
Very |
3 | 3% |
|
|---|---|---|---|
Somewhat |
16 | 13% |
|
A little |
14 | 12% |
|
Not at all |
86 | 72% |
|
Cost
Paid out of pocket
Cost of Carisoprodol
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
1 | 1% |
|
$50-99 |
2 | 2% |
|
$25-49 |
10 | 11% |
|
< $25 |
74 | 85% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 12, 2012.